An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib (ReAlec)
A Multicenter Non-Interventional Cohort Study to Evaluate the Real-World Clinical Management and Outcomes of Patients Diagnosed With ALK-Positive Advanced NSCLC Treated With Alectinib (ReAlec)
Sponsor: Hoffmann-La Roche
Listed as NCT04764188, this observational or N/A phase trial focuses on NSCLC and remains ongoing. Sponsored by Hoffmann-La Roche, it has been updated 43 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
43 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting
-
Nov 2025 — Feb 2026 [monthly]
Active Not Recruiting
-
Sep 2025 — Nov 2025 [monthly]
Active Not Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Active Not Recruiting
-
May 2025 — Aug 2025 [monthly]
Active Not Recruiting
▶ Show 38 earlier versions
-
Feb 2025 — May 2025 [monthly]
Active Not Recruiting
-
Nov 2024 — Feb 2025 [monthly]
Active Not Recruiting
-
Oct 2024 — Nov 2024 [monthly]
Active Not Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Mar 2024 — Jun 2024 [monthly]
Active Not Recruiting
-
Dec 2023 — Mar 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2023 — Dec 2023 [monthly]
Recruiting
-
Oct 2023 — Nov 2023 [monthly]
Recruiting
-
Sep 2023 — Oct 2023 [monthly]
Recruiting
-
Aug 2023 — Sep 2023 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Jul 2023 — Aug 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2023 — Jul 2023 [monthly]
Recruiting
-
May 2023 — Jun 2023 [monthly]
Recruiting
-
Apr 2023 — May 2023 [monthly]
Recruiting
-
Mar 2023 — Apr 2023 [monthly]
Recruiting
-
Feb 2023 — Mar 2023 [monthly]
Recruiting
-
Jan 2023 — Feb 2023 [monthly]
Recruiting
-
Dec 2022 — Jan 2023 [monthly]
Recruiting
-
Nov 2022 — Dec 2022 [monthly]
Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Recruiting
-
Jun 2022 — Jul 2022 [monthly]
Recruiting
-
May 2022 — Jun 2022 [monthly]
Recruiting
-
Apr 2022 — May 2022 [monthly]
Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Recruiting
-
Feb 2022 — Mar 2022 [monthly]
Recruiting
-
Jan 2022 — Feb 2022 [monthly]
Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Recruiting
-
Oct 2021 — Nov 2021 [monthly]
Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Recruiting
-
Jun 2021 — Sep 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting
-
Apr 2021 — May 2021 [monthly]
Not Yet Recruiting
-
Mar 2021 — Apr 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hoffmann-La Roche
For direct contact, visit the study record on ClinicalTrials.gov .